Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Growth factors synthesized by ovarian somatic cells directly affect oocyte growth and function. Additionally we are shipping GDF9 Kits (33) and GDF9 Proteins (13) and many more products for this protein.
Showing 10 out of 123 products:
Human Polyclonal GDF9 Primary Antibody for EIA, IHC (p) - ABIN952487
Bokobza, Ye, Kynaston, Jiang: GDF-9 promotes the growth of prostate cancer cells by protecting them from apoptosis. in Journal of cellular physiology 2010
Show all 3 references for ABIN952487
Human Polyclonal GDF9 Primary Antibody for EIA, IHC (p) - ABIN357463
Vitt, Mazerbourg, Klein, Hsueh: Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. in Biology of reproduction 2002
Show all 2 references for ABIN357463
Human Polyclonal GDF9 Primary Antibody for IHC (p), WB - ABIN388822
Hendarto, Prabowo, Moeloek, Soetjipto: Growth differentiation factor 9 concentration in the follicular fluid of infertile women with endometriosis. in Fertility and sterility 2010
Show all 2 references for ABIN388822
GDF9 expression was highest in primary growth follicles and gradually decreased during follicular development. Lowest level was found in fully grown follicles. It was maintained through fertilization and early embryonic development until gastrulation.
these results indicated that the GDF9 C447T SNP is a possible candidate genetic risk factor for female infertility in the Polish population.
GDF-9 promotes the proliferation and migration of keloid fibroblasts via a mechanism involving the Smad2 (show SMAD2 Antibodies)/3 pathway.
GDF9 c.169G>T (D57Y), c.546G>A (rs1049127), and BMP15 (show BMP15 Antibodies) rs79377927 (788_789insTCT) were associated with premature ovarian failure in the Chinese Hui population.
results support a model of activation for human GDF9 dependent on cumulin formation through heterodimerization with BMP15 (show BMP15 Antibodies). Oocyte-secreted cumulin is likely to be a central regulator of fertility in mono-ovular mammals.
GDF-9 and GDF-15 (show GDF15 Antibodies) levels may influence bone parameters in polycystic ovary syndrome
GDF9 and BMP15 (show BMP15 Antibodies) expression is reduced in primordial, primary, and secondary follicles in ovarian tissues of PCOS patients.
The arginine residue in the pre-helix loop of GDF9 homodimer may prevent the inhibition from its pro-domain or directly alter receptor binding, but this residue in GDF9 does not significantly affect the heterodimer activity.
Eleven unique copy number changes are identified in a total of 11 patients, including a tandem duplication of 475 bp, containing part of the GDF9 gene promoter region.
Data suggest up-regulation of mRNA for GDF9 and BMP15 (bone morphogenetic protein 15 (show BMP15 Antibodies)) in cumulus granulosa cells serves as biomarker for oocyte maturation, fertilization, embryo quality, and pregnancy in couples undergoing ICSI for male infertility.
These results suggest that COCs cultured with recombinant GDF9 in oocyte maturation medium improve oocyte developmental competence and subsequent developmental competence of cloned embryo in cattle.
In organogenesis of the ovary, production of Dhh (show DHH Antibodies)/Ihh (show IHH Antibodies) in granulosa cells requires growth differentiation factor 9 from the oocyte.
The arginine residue in the pre-helix loop of GDF9 homodimer may prevent the inhibition from its pro-domain or directly alter receptor binding, but this residue in GDF9 does not significantly affect the heterodimer activity during heterodimer formation.
modified oocyte glycoproteins alter GDF9:BMP15 (show BMP15 Antibodies) expression modifying follicle development resulting in the generation of more follicles
A novel role for GDF9 in causing reproductive defects and suppressing tumor initiation in the Inha (show INHA Antibodies)(-/-) mouse model.
Embryo vitrification has no effect on ovarian morphology or expression of GDF9.
The results show that chronic unpredictable stress suppresses GDF9 expression.
show that purified mature regions of GDF9 and BMP15 (show BMP15 Antibodies) synergistically interact in a specific manner which is not dependent on the presence of a pro-region.
GDF9 may contribute to the variation observed in follicular development, ovulation rate, and fecundity between mammals
Data indicate that GDF-9 is absent in follicles of obese anovulatory/PCOS ovaries; upon treatment by heterotopic transplantation of gonadal adipose tissue from lean mice, expression of GDF-9 and ovulation appear to resume.
These results show that GDF9 and BMP15 (show BMP15 Antibodies) participate in cumulus expansion and that they stimulate MPF (show MSLN Antibodies) and MAPK (show MAPK1 Antibodies) activities in porcine oocytes during in vitro maturation.
Report temporal regulation of GDF9 mRNA expression in the oocyte, granulosa and theca cells of developing preovulatory follicles in the pig.
injection of porcine GDF-9 gene resulted in an increase in the number of primary, secondary and tertiary ovarian follicles
Porcine GDF9 gene was found to be highly expressed in immature oocytes and declined slowly during the oocyte maturation process
GDF9 may be not associated with pig litter size in extensive populations as per the studies of allele distributions of the four polymorphisms and pilot association in four breeds.
Immunization against GDF9 and BMP15 (show BMP15 Antibodies), alone or together, altered follicular development and ovulation rate in cattle.
GDF9 expression in the oocytes of calf ovaries was significantly higher than in those of the adult ovaries
GDF-9 mediates its effect through the pathway commonly activated by TGF beta (show TGFB1 Antibodies) and activin (show Actbeta Antibodies), but not that activated by many BMPs
Maternal GDF9 transcripts persisted during oocyte in vitro maturation and fertilization and in preimplantation embryo until the five- to eight-cell or morula stage, but transcription was not reactivated at the time of embryonic genome activation.
Oocyte- and granulosa cell-derived GDF9 may simultaneously promote theca cell proliferation and prevent premature differentiation of the theca interna during early follicle development.
A non-synonymous mutation in GDF9 is highly associated with litter size in Chinese cashmere goats
Studied six SNPs in goat BMPR1B (show BMPR1B Antibodies), BMP15 (show BMP15 Antibodies), and GDF9 for their association with litter size in seven breeds of Indian goats. Found no association between these SNPs and prolificacy in the breeds investigated.
Expression of BMP15 (show BMP15 Antibodies) (p < 0.01) and GDF9 (p < 0.05) mRNAs was more abundant in the small than the large antral follicles of Black Bengal goat.
GNRH1 (show GNRH1 Antibodies) and GDF9 genes could serve as genetic markers for litter size in goat breeding.
Mutation A959C in GDF9 gene has been associated with prolificacy.
Expression levels of follicular GDF9 and total ovarian BMPR1B (show BMPR1B Antibodies) were not different between the Lezhi black goat and the Tibetan goat.
These results provide further evidence that the GDF9 gene may be significantly correlated with high prolificacy in goats.
Growth factors synthesized by ovarian somatic cells directly affect oocyte growth and function. Growth differentiation factor-9 (GDF9) is expressed in oocytes and is thought to be required for ovarian folliculogenesis. GDF9 is a member of the transforming growth factor-beta superfamily.
growth and differentiation factor 9
, growth/differentiation factor 9
, growth differentiation factor-9